Literature DB >> 36064588

Biomarker testing in cancer management- can one size fit all?

Lynette M Sholl1, Balazs Halmos2.   

Abstract

Biomarker-guided treatment selection has transformed cancer management. Pruis et al. provide a powerful example of the challenges and promises of whole genome sequencing to match patients with advanced cancer for precision oncology studies and targeted therapies. Expanding genomic testing platforms are reviewed with a view towards future applications to inform clinical cancer research and practice.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 36064588      PMCID： PMC9519751          DOI： 10.1038/s41416-022-01967-4

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   9.075


  10 in total

Review 1.  Whole-Genome Sequencing in Cancer.

Authors:  Eric Y Zhao; Martin Jones; Steven J M Jones
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

2.  Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.

Authors:  Eric J Duncavage; Molly C Schroeder; Michele O'Laughlin; Roxanne Wilson; Sandra MacMillan; Andrew Bohannon; Scott Kruchowski; John Garza; Feiyu Du; Andrew E O Hughes; Josh Robinson; Emma Hughes; Sharon E Heath; Jack D Baty; Julie Neidich; Matthew J Christopher; Meagan A Jacoby; Geoffrey L Uy; Robert S Fulton; Christopher A Miller; Jacqueline E Payton; Daniel C Link; Matthew J Walter; Peter Westervelt; John F DiPersio; Timothy J Ley; David H Spencer
Journal:  N Engl J Med       Date:  2021-03-11       Impact factor: 91.245

3.  Rapid Sequencing-Based Diagnosis of Thiamine Metabolism Dysfunction Syndrome.

Authors:  Mallory J Owen; Anna-Kaisa Niemi; David P Dimmock; Mark Speziale; Mark Nespeca; Kevin K Chau; Luca Van Der Kraan; Meredith S Wright; Christian Hansen; Narayanan Veeraraghavan; Yan Ding; Jerica Lenberg; Shimul Chowdhury; Charlotte A Hobbs; Sergey Batalov; Zhanyang Zhu; Shareef A Nahas; Sheldon Gilmer; Gail Knight; Sebastien Lefebvre; John Reynders; Thomas Defay; Jacqueline Weir; Vicki S Thomson; Louise Fraser; Bryan R Lajoie; Tim K McPhail; Shyamal S Mehtalia; Chris M Kunard; Kevin P Hall; Stephen F Kingsmore
Journal:  N Engl J Med       Date:  2021-06-03       Impact factor: 91.245

4.  Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer.

Authors:  Marie Wong; Chelsea Mayoh; Loretta M S Lau; David S Ziegler; Paul G Ekert; Mark J Cowley; Dong-Anh Khuong-Quang; Mark Pinese; Amit Kumar; Paulette Barahona; Emilie E Wilkie; Patricia Sullivan; Rachel Bowen-James; Mustafa Syed; Iñigo Martincorena; Federico Abascal; Alexandra Sherstyuk; Noemi A Bolanos; Jonathan Baber; Peter Priestley; M Emmy M Dolman; Emmy D G Fleuren; Marie-Emilie Gauthier; Emily V A Mould; Velimir Gayevskiy; Andrew J Gifford; Dylan Grebert-Wade; Patrick A Strong; Elodie Manouvrier; Meera Warby; David M Thomas; Judy Kirk; Katherine Tucker; Tracey O'Brien; Frank Alvaro; Geoffry B McCowage; Luciano Dalla-Pozza; Nicholas G Gottardo; Heather Tapp; Paul Wood; Seong-Lin Khaw; Jordan R Hansford; Andrew S Moore; Murray D Norris; Toby N Trahair; Richard B Lock; Vanessa Tyrrell; Michelle Haber; Glenn M Marshall
Journal:  Nat Med       Date:  2020-10-05       Impact factor: 53.440

5.  Tracking the Evolution of Non-Small-Cell Lung Cancer.

Authors:  Mariam Jamal-Hanjani; Gareth A Wilson; Nicholas McGranahan; Nicolai J Birkbak; Thomas B K Watkins; Selvaraju Veeriah; Seema Shafi; Diana H Johnson; Richard Mitter; Rachel Rosenthal; Max Salm; Stuart Horswell; Mickael Escudero; Nik Matthews; Andrew Rowan; Tim Chambers; David A Moore; Samra Turajlic; Hang Xu; Siow-Ming Lee; Martin D Forster; Tanya Ahmad; Crispin T Hiley; Christopher Abbosh; Mary Falzon; Elaine Borg; Teresa Marafioti; David Lawrence; Martin Hayward; Shyam Kolvekar; Nikolaos Panagiotopoulos; Sam M Janes; Ricky Thakrar; Asia Ahmed; Fiona Blackhall; Yvonne Summers; Rajesh Shah; Leena Joseph; Anne M Quinn; Phil A Crosbie; Babu Naidu; Gary Middleton; Gerald Langman; Simon Trotter; Marianne Nicolson; Hardy Remmen; Keith Kerr; Mahendran Chetty; Lesley Gomersall; Dean A Fennell; Apostolos Nakas; Sridhar Rathinam; Girija Anand; Sajid Khan; Peter Russell; Veni Ezhil; Babikir Ismail; Melanie Irvin-Sellers; Vineet Prakash; Jason F Lester; Malgorzata Kornaszewska; Richard Attanoos; Haydn Adams; Helen Davies; Stefan Dentro; Philippe Taniere; Brendan O'Sullivan; Helen L Lowe; John A Hartley; Natasha Iles; Harriet Bell; Yenting Ngai; Jacqui A Shaw; Javier Herrero; Zoltan Szallasi; Roland F Schwarz; Aengus Stewart; Sergio A Quezada; John Le Quesne; Peter Van Loo; Caroline Dive; Allan Hackshaw; Charles Swanton
Journal:  N Engl J Med       Date:  2017-04-26       Impact factor: 91.245

6.  Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.

Authors:  Arezou A Ghazani; Nelly M Oliver; Joseph P St Pierre; Andrea Garofalo; Irene R Rainville; Elaine Hiller; Daniel J Treacy; Vanesa Rojas-Rudilla; Sam Wood; Elizabeth Bair; Michael Parello; Franklin Huang; Marios Giannakis; Frederick H Wilson; Elizabeth H Stover; Steven M Corsello; Tom Nguyen; Huma Q Rana; Alanna J Church; Carol Lowenstein; Carrie Cibulskis; Ali Amin-Mansour; Jennifer Heng; Lauren Brais; Abigail Santos; Patrick Bauer; Amanda Waldron; Peter Lo; Megan Gorman; Christine A Lydon; Marisa Welch; Philip McNamara; Stacey Gabriel; Lynette M Sholl; Neal I Lindeman; Judy E Garber; Steven Joffe; Eliezer M Van Allen; Stacy W Gray; Pasi A Ja Nne; Levi A Garraway; Nikhil Wagle
Journal:  Genet Med       Date:  2017-01-26       Impact factor: 8.822

7.  Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.

Authors:  Stefan C Dentro; Ignaty Leshchiner; Kerstin Haase; Maxime Tarabichi; Jeff Wintersinger; Amit G Deshwar; Kaixian Yu; Yulia Rubanova; Geoff Macintyre; Jonas Demeulemeester; Ignacio Vázquez-García; Kortine Kleinheinz; Dimitri G Livitz; Salem Malikic; Nilgun Donmez; Subhajit Sengupta; Pavana Anur; Clemency Jolly; Marek Cmero; Daniel Rosebrock; Steven E Schumacher; Yu Fan; Matthew Fittall; Ruben M Drews; Xiaotong Yao; Thomas B K Watkins; Juhee Lee; Matthias Schlesner; Hongtu Zhu; David J Adams; Nicholas McGranahan; Charles Swanton; Gad Getz; Paul C Boutros; Marcin Imielinski; Rameen Beroukhim; S Cenk Sahinalp; Yuan Ji; Martin Peifer; Inigo Martincorena; Florian Markowetz; Ville Mustonen; Ke Yuan; Moritz Gerstung; Paul T Spellman; Wenyi Wang; Quaid D Morris; David C Wedge; Peter Van Loo
Journal:  Cell       Date:  2021-04-07       Impact factor: 41.582

8.  Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome.

Authors:  Michael Rusch; Joy Nakitandwe; Sheila Shurtleff; Scott Newman; Zhaojie Zhang; Michael N Edmonson; Matthew Parker; Yuannian Jiao; Xiaotu Ma; Yanling Liu; Jiali Gu; Michael F Walsh; Jared Becksfort; Andrew Thrasher; Yongjin Li; James McMurry; Erin Hedlund; Aman Patel; John Easton; Donald Yergeau; Bhavin Vadodaria; Ruth G Tatevossian; Susana Raimondi; Dale Hedges; Xiang Chen; Kohei Hagiwara; Rose McGee; Giles W Robinson; Jeffery M Klco; Tanja A Gruber; David W Ellison; James R Downing; Jinghui Zhang
Journal:  Nat Commun       Date:  2018-09-27       Impact factor: 14.919

9.  Pan-cancer whole-genome analyses of metastatic solid tumours.

Authors:  Peter Priestley; Jonathan Baber; Martijn P Lolkema; Neeltje Steeghs; Ewart de Bruijn; Charles Shale; Korneel Duyvesteyn; Susan Haidari; Arne van Hoeck; Wendy Onstenk; Paul Roepman; Mircea Voda; Haiko J Bloemendal; Vivianne C G Tjan-Heijnen; Carla M L van Herpen; Mariette Labots; Petronella O Witteveen; Egbert F Smit; Stefan Sleijfer; Emile E Voest; Edwin Cuppen
Journal:  Nature       Date:  2019-10-23       Impact factor: 49.962

10.  Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high frequency of cancer prone syndromes.

Authors:  Anna Byrjalsen; Thomas V O Hansen; Ulrik K Stoltze; Mana M Mehrjouy; Nanna Moeller Barnkob; Lisa L Hjalgrim; René Mathiasen; Charlotte K Lautrup; Pernille A Gregersen; Henrik Hasle; Peder S Wehner; Ruta Tuckuviene; Peter Wad Sackett; Adrian O Laspiur; Maria Rossing; Rasmus L Marvig; Niels Tommerup; Tina Elisabeth Olsen; David Scheie; Ramneek Gupta; Anne-Marie Gerdes; Kjeld Schmiegelow; Karin Wadt
Journal:  PLoS Genet       Date:  2020-12-17       Impact factor: 5.917
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.